NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologiesBOSTON, Dec. 14, 2023 /PRNewswire/ -- ArisGlobal, a market leader in Life Sciences technology and the creator of LifeSphere®, has today launched LifeSphere NavaX, a cutting-edge cognitive computing engine to expedite R&D IT Digitization by leveraging advanced technologies including Large Language Models (LLM) and Generative AI (Gen AI)..

NavaX将利用最新的先进技术彻底改变端到端的研究和开发流程波士顿，2023年12月14日/PRNewswire/--生命科学技术的市场领导者和LifeSphere®的创始人ArisGlobal今天推出了LifeSphere NavaX，一个尖端的认知计算引擎，通过利用包括大型语言模型（LLM）和生成人工智能（Gen-AI）在内的先进技术来加速研发IT数字化。。

Continue Reading

继续阅读

ArisGlobal Logo (PRNewsfoto/ArisGlobal)

ArisGlobal标志（PRNewsFoto/ArisGlobal）

LifeSphere is the industry's leading R&D compliance platform. In 2018, the company introduced LifeSphere MultiVigilance (LSMV), a platform for individual case safety report (ICSR) intake. LSMV was powered by LifeSphere Nava (v1) – at introduction, LifeSphere Nava offered the latest robotic process automation and cognitive computing technologies, including natural language processing (NLP) and machine learning (ML), to transform pharmacovigilance (PV) activities..

LifeSphere是业界领先的研发合规平台。2018年，该公司推出了LifeSphere MultiVigilance（LSMV），这是一个用于个案安全报告（ICSR）摄入的平台。LSMV由LifeSphere Nava（v1）提供动力–简介时，LifeSphere Nava提供了最新的机器人过程自动化和认知计算技术，包括自然语言处理（NLP）和机器学习（ML），以改变药物警戒（PV）活动。。

Today, LifeSphere NavaX includes next-generation technologies that will bring comprehensive efficiency gains across the end-to-end PV and regulatory processes. Organizations leveraging LifeSphere NavaX will benefit from the latest developments from ArisGlobal, including:

如今，LifeSphere NavaX包括新一代技术，这些技术将在端到端光伏和监管过程中带来全面的效率收益。利用LifeSphere NavaX的组织将受益于ArisGlobal的最新发展，包括：

Proactive Signal Detection (with the use of Real-World Data),

主动信号检测（使用真实数据），

Generative AI (Gen AI), and

生成AI（Gen AI），以及

Large Language Models (LLM) features and functionality

大型语言模型（LLM）的特性和功能

Half (49%) of all Life Sciences organizations have cited a desire to deploy Gen AI in the next 12 months, in a survey conducted for the Gartner 2024 CIO Agenda, with 15% pointing to deployment within 12-24 months; only 8% having deployed the technology already. The growing appetite for smart process automation reflects the soaring pressure on Life Sciences companies and their PV and Regulatory operations to be more agile and efficient, uphold the highest standards of patient safety while improving quality and compliance.Aman Wasan, CEO of ArisGlobal, said: 'Our vision is to transform the R&D IT ecosystem with advanced technology.

在为Gartner 2024 CIO议程进行的一项调查中，所有生命科学组织中有一半（49%）表示希望在未来12个月内部署Gen AI，其中15%表示在12-24个月内部署；只有8%的人已经部署了这项技术。人们对智能流程自动化的需求日益增长，这反映出生命科学公司及其光伏和监管运营面临的巨大压力，需要更加灵活和高效，在提高质量和合规性的同时，维护患者安全的最高标准。ArisGlobal首席执行官阿曼·瓦桑（AmanWasan）表示：“我们的愿景是用先进技术改造研发IT生态系统。

NavaX will help global pharmaceutical, biotech, and health authorities achieve greater value leveraging cutting-edge technology. With more than 30 years of experience in the Life Sciences industry,  ArisGlobal team will work closely with each customer to unlock exceptional benefits with NavaX.' Ann-Marie Orange, CIO & Global Head of R&D at ArisGlobal said, 'Companies are facing monumental challenges including increasing case volume, balancing the need to elevate drug safety and efficacy while containing rising R&D costs, responding to regulatory complexity, and a growing pressure to harness big data and analytics.

NavaX将帮助全球制药、生物技术和卫生部门利用尖端技术实现更大的价值。凭借在生命科学行业30多年的经验，ArisGlobal团队将与每位客户密切合作，利用NavaX实现卓越的收益。”ArisGlobal首席信息官兼全球研发主管安·玛丽·奥兰治（AnnMarieOrange）表示，“公司面临着巨大的挑战，包括增加病例数量，平衡提高药物安全性和有效性的需求，同时控制不断上升的研发成本，应对监管复杂性，以及利用大数据和分析的压力越来越大。

Compounding these challenges, there remain inefficient legacy IT systems, workflows, and processes, along with budget and resource constraints.' Orange adds, 'Our LifeSphere platform codifies decades of R&D and compliance expertise, making it available to our customers. LifeSphere NavaX builds on our proven platform, allowing the Life Sciences industry access to digital innovations that are driving the world forward.'NavaX Technology Highlights.

使这些挑战更加复杂的是，仍然存在效率低下的遗留IT系统、工作流程和流程，以及预算和资源限制。”Orange补充道，“我们的LifeSphere平台汇集了数十年的研发和法规遵从性专业知识，可供客户使用。LifeSphere NavaX建立在我们经过验证的平台上，使生命科学行业能够获得推动世界前进的数字创新。”NavaX技术亮点。

NavaX is scalable and customizable; allows PV and Regulatory teams to remain in control and set their own pace based on their objectives, goals, and timing.

NavaX具有可扩展性和可定制性；允许PV和监管团队保持控制，并根据其目标、目标和时间安排设定自己的节奏。

NavaX supercharges LifeSphere solutions, which seamlessly integrate with third-party systems to ensure a smooth transition to a more intelligent and automated future.

NavaX增强了LifeSphere解决方案的性能，该解决方案与第三方系统无缝集成，以确保平稳过渡到更智能和自动化的未来。

NavaX is built and enhanced with continuous inputs from pharmaceutical and regulatory partners, with the highest standards within the establishment of robust governance frameworks and compliance standards.

NavaX是在制药和监管合作伙伴的持续投入下构建和增强的，在建立健全的治理框架和合规标准方面具有最高标准。

Today, more than 500 global pharmaceutical and biotech companies (90% of the Top 10 pharma brands) leverage LifeSphere, ArisGlobal's open R&D and compliance platform transforming the way Life Science companies develop breakthroughs and bring new patient treatments to market, faster. Current LifeSphere platform customers have achieved exceptional process efficiency gains and cost savings.

如今，全球500多家制药和生物技术公司（前10大制药品牌中的90%）利用LifeSphere，ArisGlobal的开放研发和合规平台，改变了生命科学公司取得突破的方式，并更快地将新的患者治疗方法推向市场。目前的LifeSphere平台客户取得了非凡的流程效率提高和成本节约。

By powering next-generation digital process innovation, NavaX will supercharge operational efficiency, drive even faster time to insights, and ensure greater compliance.Learn more about LifeSphere NavaX, here.About ArisGlobalArisGlobal is the creator of LifeSphere, a market leader in global patient treatment technology solutions that is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market.

通过推动下一代数字流程创新，NavaX将提高运营效率，加快洞察时间，并确保更高的法规遵从性。在此了解有关LifeSphere NavaX的更多信息。关于ArisGlobalArisGlobal是LifeSphere的创始人，LifeSphere是全球患者治疗技术解决方案的市场领导者，正在改变当今最成功的生命科学公司开发突破并将新产品推向市场的方式。

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn and www.arisglobal.com.SOURCE ArisGlobal.

ArisGlobal总部位于美国，在欧洲、印度、日本和中国设有区域办事处。有关更多更新，请关注LinkedIn上的ArisGlobal和www.ArisGlobal.com.SOURCE ArisGlobal。